Cargando…
Correction: Development, implementation, and feasibility of site‑specific hepatitis C virus treatment workflows for treating vulnerable, high‑risk populations: protocol of the Erase Hep C study — a prospective single‑arm intervention trial
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311777/ https://www.ncbi.nlm.nih.gov/pubmed/37391830 http://dx.doi.org/10.1186/s40814-023-01347-6 |
| _version_ | 1785066813022797824 |
|---|---|
| author | Desai, Anmol O’Neal, Lauren Reinis, Kia Chang, Patrick Brown, Cristal Stefanowicz, Michael Kuang, Audrey Agrawal, Deepak Bhavnani, Darlene Mercer, Tim |
| author_facet | Desai, Anmol O’Neal, Lauren Reinis, Kia Chang, Patrick Brown, Cristal Stefanowicz, Michael Kuang, Audrey Agrawal, Deepak Bhavnani, Darlene Mercer, Tim |
| author_sort | Desai, Anmol |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10311777 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103117772023-07-01 Correction: Development, implementation, and feasibility of site‑specific hepatitis C virus treatment workflows for treating vulnerable, high‑risk populations: protocol of the Erase Hep C study — a prospective single‑arm intervention trial Desai, Anmol O’Neal, Lauren Reinis, Kia Chang, Patrick Brown, Cristal Stefanowicz, Michael Kuang, Audrey Agrawal, Deepak Bhavnani, Darlene Mercer, Tim Pilot Feasibility Stud Correction BioMed Central 2023-06-30 /pmc/articles/PMC10311777/ /pubmed/37391830 http://dx.doi.org/10.1186/s40814-023-01347-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Desai, Anmol O’Neal, Lauren Reinis, Kia Chang, Patrick Brown, Cristal Stefanowicz, Michael Kuang, Audrey Agrawal, Deepak Bhavnani, Darlene Mercer, Tim Correction: Development, implementation, and feasibility of site‑specific hepatitis C virus treatment workflows for treating vulnerable, high‑risk populations: protocol of the Erase Hep C study — a prospective single‑arm intervention trial |
| title | Correction: Development, implementation, and feasibility of site‑specific hepatitis C virus treatment workflows for treating vulnerable, high‑risk populations: protocol of the Erase Hep C study — a prospective single‑arm intervention trial |
| title_full | Correction: Development, implementation, and feasibility of site‑specific hepatitis C virus treatment workflows for treating vulnerable, high‑risk populations: protocol of the Erase Hep C study — a prospective single‑arm intervention trial |
| title_fullStr | Correction: Development, implementation, and feasibility of site‑specific hepatitis C virus treatment workflows for treating vulnerable, high‑risk populations: protocol of the Erase Hep C study — a prospective single‑arm intervention trial |
| title_full_unstemmed | Correction: Development, implementation, and feasibility of site‑specific hepatitis C virus treatment workflows for treating vulnerable, high‑risk populations: protocol of the Erase Hep C study — a prospective single‑arm intervention trial |
| title_short | Correction: Development, implementation, and feasibility of site‑specific hepatitis C virus treatment workflows for treating vulnerable, high‑risk populations: protocol of the Erase Hep C study — a prospective single‑arm intervention trial |
| title_sort | correction: development, implementation, and feasibility of site‑specific hepatitis c virus treatment workflows for treating vulnerable, high‑risk populations: protocol of the erase hep c study — a prospective single‑arm intervention trial |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311777/ https://www.ncbi.nlm.nih.gov/pubmed/37391830 http://dx.doi.org/10.1186/s40814-023-01347-6 |
| work_keys_str_mv | AT desaianmol correctiondevelopmentimplementationandfeasibilityofsitespecifichepatitiscvirustreatmentworkflowsfortreatingvulnerablehighriskpopulationsprotocoloftheerasehepcstudyaprospectivesinglearminterventiontrial AT oneallauren correctiondevelopmentimplementationandfeasibilityofsitespecifichepatitiscvirustreatmentworkflowsfortreatingvulnerablehighriskpopulationsprotocoloftheerasehepcstudyaprospectivesinglearminterventiontrial AT reiniskia correctiondevelopmentimplementationandfeasibilityofsitespecifichepatitiscvirustreatmentworkflowsfortreatingvulnerablehighriskpopulationsprotocoloftheerasehepcstudyaprospectivesinglearminterventiontrial AT changpatrick correctiondevelopmentimplementationandfeasibilityofsitespecifichepatitiscvirustreatmentworkflowsfortreatingvulnerablehighriskpopulationsprotocoloftheerasehepcstudyaprospectivesinglearminterventiontrial AT browncristal correctiondevelopmentimplementationandfeasibilityofsitespecifichepatitiscvirustreatmentworkflowsfortreatingvulnerablehighriskpopulationsprotocoloftheerasehepcstudyaprospectivesinglearminterventiontrial AT stefanowiczmichael correctiondevelopmentimplementationandfeasibilityofsitespecifichepatitiscvirustreatmentworkflowsfortreatingvulnerablehighriskpopulationsprotocoloftheerasehepcstudyaprospectivesinglearminterventiontrial AT kuangaudrey correctiondevelopmentimplementationandfeasibilityofsitespecifichepatitiscvirustreatmentworkflowsfortreatingvulnerablehighriskpopulationsprotocoloftheerasehepcstudyaprospectivesinglearminterventiontrial AT agrawaldeepak correctiondevelopmentimplementationandfeasibilityofsitespecifichepatitiscvirustreatmentworkflowsfortreatingvulnerablehighriskpopulationsprotocoloftheerasehepcstudyaprospectivesinglearminterventiontrial AT bhavnanidarlene correctiondevelopmentimplementationandfeasibilityofsitespecifichepatitiscvirustreatmentworkflowsfortreatingvulnerablehighriskpopulationsprotocoloftheerasehepcstudyaprospectivesinglearminterventiontrial AT mercertim correctiondevelopmentimplementationandfeasibilityofsitespecifichepatitiscvirustreatmentworkflowsfortreatingvulnerablehighriskpopulationsprotocoloftheerasehepcstudyaprospectivesinglearminterventiontrial |